The orthopedic implant market has growth in store and is expected to hit $8.97 billion by 2025, according to a January report from Fior Markets.
Spinal Tech
From one acquisition in the foot and ankle space to two new product launches, here are the latest device company notes:
Orthopedic device company Sacrix launched the third iteration of SacroFuse, a threaded compression device designed for immediate stabilization of the sacroiliac joint.
Here are three devices that were launched in December:
Conformis and Sites Medical are forming a nonexclusive development and supply agreement, according to a Jan. 21 news release.
Four acquisitions in the orthopedic device industry in the past month:
Driven by recent acquisitions, the orthopedic devices market is expected to grow at a 4 percent compound annual growth rate through 2025, according to a GlobalData report.
Zimmer Biomet's Bactiguard-coated orthopedic trauma implants received European regulatory clearance and CE mark on Jan. 21.
New York City-based Hospital for Special Surgery orthopedic surgeon Jonathan Vigdorchik, MD, performed the first knee-replacement procedure in the U.S. assisted by augmented reality, The Wall Street Journal reported Jan. 21.
The device company industry is constantly changing, with mergers and acquisitions rife within the orthopedic market through 2020 and into 2021.
